Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study
1997; Elsevier BV; Volume: 221; Issue: 2-3 Linguagem: Inglês
10.1016/s0304-3940(96)13278-x
ISSN1872-7972
AutoresMikhail B. Bogdanov, Richard J. Wurtman,
Tópico(s)Receptor Mechanisms and Signaling
ResumoThe involvement of nitric oxide (NO) production in the release of striatal glutamate induced by local infusion of N-methyl-d-aspartate (NMDA) was investigated using microdialysis in freely moving rats. At concentrations of 0.1, 0.25, 0.5 or 1 mM NMDA induced concentration-dependent increases in striatal glutamate release. This effect of NMDA (0.5 mM) was significantly inhibited by tetrodotoxin (10 μM), by striatal perfusion with Ca2+-free medium containing EGTA (5 mM), or by the putative antagonist of intracellular Ca2+, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) (1, 10 or 100 μM). Local infusion of the competitive inhibitors of NO synthase (NOS), NG-nitro-l-arginine methyl ester (l-NAME) or NG-monomethyl-l-arginine (l-NMMA) (both at concentrations 0.1, 0.25, 0.5 or 1 mM) caused the concentration-dependent inhibition of the glutamate response to 0.5 mM NMDA. This effect of NOS inhibition was stereospecific, inasmuch as NG-nitro-d-arginine methyl ester (d-NAME) (0.5 or 1 mM) failed to affect NMDA-induced glutamate release. These findings suggest that increased NO production following NMDA receptor activation mediates the increase in release of neurotransmitter glutamate triggered by activation of striatal NMDA receptors.
Referência(s)